Cardiac Wire #40 December 1, 2022
The Heart & ADHD Meds | Rethinking HDL-C
Cardiac Wire #38 November 21, 2022
New Antihypertensive on the Block | Elon Musk & Eli Lilly Twitter Fallout
Cardiac Wire #39 November 21, 2022
FDA Cracks Down on Heart Supplements | Ticagrelor vs. Prasugrel in CAD
Cardiac Wire #37 November 17, 2022
The Cryoablation Advantage | ReCor’s Renal Denervation Win
Cardiac Wire #36 November 14, 2022
Statins Obliterate OTC Heart Supplements
Cardiac Wire #35 November 10, 2022
Amgen’s Olpasiran Slashes Lp(a) Levels | AHA Study Rollout
Cardiac Wire #34 November 7, 2022
CW Q&A: Us2.ai’s Strain Analysis Feature | The Future of In-Home Ultrasound
Cardiac Wire #33 November 3, 2022
J&J’s $16.6B Abiomed Acquisition | AFib Insights
Cardiac Wire #32 October 31, 2022
Cleerly’s Image Transfer Solution | Common Drugs Tied to AFib
Cardiac Wire #31 October 27, 2022
Persistent AFib Breakthrough | Smartphone Stethoscope App
Cardiac Wire #30 October 24, 2022
Abiomed Is on a Roll | How Do Residents View Cardiology?
Cardiac Wire #29 October 20, 2022
HeartFlow Plaque & Roadmap | Metformin for AFib
Cardiac Wire #28 October 17, 2022
Paxlovid Interacts with Heart Drugs | Healthcare Hiring Recovery
Cardiac Wire #27 October 13, 2022
Merck’s $11B Bet Pays Off | Why Pollution Causes Heart Attacks
Cardiac Wire #26 October 10, 2022
Challenging the Salt Restriction Norm | Speech Analysis App Predicts HF
Cardiac Wire #25 October 6, 2022
SGLT2i: A Universal HF Solution? | ECG-AI Boosts AFib Detection
Cardiac Wire #24 September 30, 2022
Plaque Reimbursement Milestone | Spironolactone for Alcohol Use Disorder
Cardiac Wire #23 September 28, 2022
Deprescribing Aspirin | Rocket Acquires Renovacor
Cardiac Wire #22 September 23, 2022
